Equity - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	280,000,000		280,000,000		280,000,000
Preferred stock, shares authorized (in shares)	50,000,000		50,000,000		50,000,000
Common stock issued in connection with stock options exercised (in shares)			14,122
Common stock issued through the dividend reinvestment plan (in shares)			1,891	1,703
Common stock issued through Employee Stock Purchase Plan (in shares)			9,875
Number of shares of stock grants withheld (in shares)			92,333	62,215
Repurchases of shares (in shares)	0	4,800	0	11,800
Stock repurchase program, remaining authorized amount	$ 314,237,000		$ 314,237,000
Treasury stock acquired (in dollars per share)		$ 162.93		$ 161.96
2020 Stock Repurchase Program
Class of Stock [Line Items]
Stock repurchase program, authorized amount	500,000,000		500,000,000
Continuous Equity Program CEP V
Class of Stock [Line Items]
Maximum value of shares of common stock that can be sold (in dollars)	$ 1,000,000,000		$ 1,000,000,000
Common stock sold under CEP V (in shares)	0	0	0	0
Common stock value, remaining to be authorized under continuous equity program	$ 705,961,000		$ 705,961,000
Restricted Stock and Common Stock Converted from Performance Shares
Class of Stock [Line Items]
Equity instruments granted (in shares)			248,420	152,708
Deferred Compensation, Share-based Payments [Member] | Non employee director
Class of Stock [Line Items]
Equity instruments granted (in shares)			12,290
Restricted stock
Class of Stock [Line Items]
Equity instruments granted (in shares)			101,695	92,692
Stock issued during period, shares, share-based compensation, forfeited (in shares)			2,702	566